Biotech
MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/28/17 -- Opthea Limited (ASX: OPT) ("Opthea"), a developer of novel biologic therapies for the treatment of eye diseases, announced today the com ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 04/27/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inbor ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 04/25/17 -- EAG Laboratories, a global scientific services company that provides testing, analytical and characterization services to technology- and life-science-re ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 04/24/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 1, ...
MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 04/24/17 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today announced that on April 21, 2017 the Company's Boa ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 04/20/17 ---- Novel genetic mutations predictive of response to AEVI-001 found in approximately 10% of pediatric ADHD patients ---- New results clarify a path forw ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 04/20/17 -- Atossa Genetics, Inc. (NASDAQ: ATOS), a clinical-stage pharmaceutical company, today announced that it has received a positive interim review on its Phase ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 04/20/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotech company devoted to treating diseases thought to be related to endogenous al ...
CHICAGO, IL: Revenue Improved 1,166 Percent and Gross Profit Improved 1,126 Percent Year over Year ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/18/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its fourth quarter and full year 2016 fina ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/18/17 -- Arch Biopartners, Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) announces the Company's board has granted a total of 2,100,000 s ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 04/18/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inbor ...
HALIFAX, NOVA SCOTIA: Study Demonstrates Broad Applicability of Immunovaccine's DepoVax(TM) Platform for Delivering Cancer Antigens ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 04/17/17 -- (NASDAQ: CBLI) today announced that the U.S. Food and Drug Administration (FDA) has completed its review of a side-by-side analytical comparison of two fo ...
BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 04/17/17 -- (NASDAQ: CBLI) today announced that the European Medicines Agency (EMA) has accepted the company's pediatric investigation plan (PIP), paving the way ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 04/13/17 -- Arch Biopartners Inc., (Arch or the Company) (TSX VENTURE: ARCH)(OTCBB: ACHFF) a portfolio-based biotechnology company, today announced that the Cinc ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/13/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to announce that it has entered into ...
PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 04/12/17 -- (NASDAQ: GNMX) (the Company) today announced that results identifying a genomic subset of responders from the SAGA trial of AEVI-001 will be presented ...
ROCKVILLE, MD: ROCKVILLE, MD -- (Marketwired) -- 04/12/17 -- , a genetic drug development company, announced the appointment of C. Neil Lyons as Executive Vice President and Chief Financial Officer.Mr. Lyons joins ...
